Given the efficacy of Avexa's drug and the many patients it has already helped, could it be that the last big pharma to say no may well be behind the current buying at bargain prices.
Leaving AVX friendless in the knowledge that the SP would collapse could be an ingenious strategy on the part of a large corp to own Avexa's intellectual property.
Is this just too nasty to be true?
